Diabetic Neuropathy
📧 Sign up to get email alerts when something new happens for Diabetic Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy [Phase 3]
Phase 3 trial investigating pregabalin versus placebo for neuropathic pain in diabetic peripheral neuropathy has completed.
-
FDA approval · 2020-09-29FDA Approved: GABAPENTIN — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Gabapentin from ScieGen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2020-05-06Clinical Trial Update: High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy [Phase 4]
Phase 4 trial comparing high versus low dose vitamin D in patients with type 2 diabetes and diabetic neuropathy.
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: A Randomized Controlled Trial of Mecobalamin Injection and Tablet Treatment Efficacy on Mild to Moderate Diabetic Peripheral Neuropathy [Phase 2]
Phase 2 randomized trial evaluating mecobalamin injection and tablet for mild to moderate diabetic peripheral neuropathy.
-
FDA approval · 2020-04-03FDA Approved: LYRICA CR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental NDA for LYRICA CR (pregabalin) submitted by Viatris Specialty LLC, indicating a regulatory approval of a supplem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Study of DA-9801 to Treat Diabetic Neuropathy [Phase 2]
Phase 2 trial update for DA-9801 in diabetic neuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy [NA]
A completed clinical trial evaluating dual field PEMF therapy for painful distal symmetric peripheral neuropathy due to diabetes.
-
CLINICAL_TRIALS trial_result · 2020-01-30Clinical Trial Update: The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Males With Diabetic Neuropathy [Phase 4]
A Phase 4 trial comparing capsaicin 8% patch to a 5% lidocaine patch in males with diabetic neuropathy completed, evaluating efficacy and sa…
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves [Phase 2]
Phase 2 trial evaluating cebranopadol for efficacy and safety in diabetic neuropathic pain; results completed with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy [Phase 2]
Phase 2 clinical trial update evaluating a water-soluble sublingual CBD tablet for pain associated with diabetic neuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Exercise-facilitated Neurorehabilitation in Diabetic Neuropathy [NA]
A completed clinical trial on exercise-facilitated neurorehabilitation for diabetic neuropathy with results posted in 2019.
-
FDA approval · 2019-05-23FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis Div of Pfizer Inc, indicating an approved modificat…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Efficacy of γ-linolenic Acid and Thioctic Acid in Patients With Diabetic Neuropathy [Phase 4]
Phase 4 clinical trial evaluating the efficacy of gamma-linolenic acid and thioctic acid in diabetic neuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy [Phase 3]
A Phase 3 trial examining muscarinic receptor antagonists as a therapy for diabetic neuropathy has completed.
-
CLINICAL_TRIALS research · 2019-02-20Clinical Trial Update: Assessments and Interventions for Hand Neuropathy in DM [NA]
This clinical-trial update summarizes assessments and interventions studied for diabetic hand neuropathy in people with diabetes, based on a…
-
CLINICAL_TRIALS trial_result · 2019-02-11Clinical Trial Update: The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes [Phase 2]
Phase 2 trial update investigating the effects of liraglutide on sudomotor function and inflammation in type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: Clinical Trial Using the Proteolytic Fraction P1G10 From V. Cundinamarcensis to Heal Diabetic Foot Ulcer [Phase 2]
Phase 2 clinical trial update evaluating P1G10 proteolytic fraction from V. cundinamarcensis for healing diabetic foot ulcers.
-
EMA withdrawal · 2018-08-07EMA Withdrawn: Ariclaim (duloxetine) — Eli Lilly Nederland B.V.
EMA withdrew Ariclaim (duloxetine) from the market in the Diabetic Neuropathies therapeutic area.
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Perineural Platelet-rich Plasma for Diabetic Neuropathy Pain [NA]
A completed clinical trial from Assiut University evaluated perineural platelet-rich plasma for diabetic neuropathy pain.
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Effect of Physical Therapy in Improving the Health of Patients With Diabetic Peripheral Neuropathy [NA]
This completed clinical trial evaluated whether physical therapy improves health outcomes for people with diabetic neuropathy.
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN). [Phase 2]
This update reports completion of a Phase 2 study evaluating RWJ-333369 (Carsibamate) for the treatment of diabetic peripheral neuropathy, f…
-
CLINICAL_TRIALS research · 2018-02-14Clinical Trial Update: PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs [Phase 4]
Phase 4 clinical trial evaluating pharmacological lowering of advanced glycation end products (AGEs) in diabetes and related conditions has …
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Can Ultrasound Predict Nerve Injury Following Posterior Tibial Nerve Block in Patients With Peripheral Neuropathy?
The clinical trial evaluates whether ultrasound can predict nerve injury after posterior tibial nerve block in patients with diabetic neurop…
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy [Phase 2]
Phase 2 clinical trial investigating clonidine hydrochloride topical gel 0.1% for pain associated with diabetic neuropathy has completed wit…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy [Phase 2]
Phase 2 trial assessing the efficacy and safety of clonidine hydrochloride topical gel versus a gel comparator for painful diabetic neuropat…